The overall goal of Part I of this study is to collect information about your leukemia and your response to the first phase of treatment, called Induction. Part I of the study is necessary to determine if you will be eligible for Part II, and to help decide the best treatment after Induction. The treatment involves cancer fighting medicines called chemotherapy. The treatment on this part of the study takes about one month.